Browsing: Beta-cell function

In patients with type 2 diabetes, once-weekly semaglutide significantly improved beta-cell function and glycaemic control compared to placebo, enhancing both insulin secretion and reducing fasting and postprandial glucose levels, though it was associated with mild gastrointestinal side effects.